Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-25-008409
Filing Date
2025-02-27
Accepted
2025-02-27 09:45:01
Documents
1
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 214579
  Complete submission text file 0001493152-25-008409.txt   215929
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-12555 | Film No.: 25673740
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)